Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker

dc.contributor.author	Pekmezci, Melike
dc.contributor.author	Phillips, Joanna J.
dc.contributor.author	Dirilenoglu, Fikret
dc.contributor.author	Atasever-Rezanko, Turkan
dc.contributor.author	Tihan, Tarik
dc.contributor.author	Solomon, David
dc.contributor.author	Bollen, Andrew
dc.contributor.author	Perry, Arie
dc.date.accessioned	2021-12-21T08:47:26Z
dc.date.available	2021-12-21T08:47:26Z
dc.date.issued	2020
dc.identifier.issn	0001-6322
dc.identifier.issn	1432-0533
dc.identifier.uri	https://doi.org/10.1007/s00401-019-02123-8
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2240
dc.description.sponsorship	UCSF Department of Pathology; NIH/NCI U01 [CA229345]; NIH Director's Early Independence AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DP5 OD021403]
dc.language.iso	English
dc.publisher	Sprınger
dc.title	Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker
dc.type	Letter
dc.relation.journal	Acta Neuropathologıca
dc.identifier.issue	3
dc.identifier.startpage	597
dc.identifier.endpage	600
dc.identifier.volume	139
dc.identifier.doi	10.1007/s00401-019-02123-8
dc.relation.issue	3
dc.relation.volume	139